Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315

EMBO Journal

Volumn 24, Issue 15, 2005, Pages 2768-2782

  Fogal, Valentina ^a   Hsieh, Jung Kuang ^a   Royer, Christophe ^a   Zhong, Shan ^a   Lu, Xin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cell cycle; E2F1; Nuclear export; p53; Ser315

Indexed keywords

CYCLIN A; PROTEIN P53; PROTEIN P63; PROTEIN P73; SERINE; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1;

APOPTOSIS; ARTICLE; CELL CYCLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION;

AMINO ACID SEQUENCE; CELL CYCLE; CELL CYCLE PROTEINS; CELL NUCLEUS; DNA; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; SERINE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 23844514818     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600735     Document Type: Article

References (31)

1. Abraham J, Kelly J, Thibault P, Benchimol S (2000) Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry. J Mol Biol 295: 853-864
2. Appella E, Anderson CW (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268: 2764-2772
3. Bischoff JR, Friedman PN, Marshak DR, Prives C, Beach D (1990) Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc Natl Acad Sci USA 87: 4766-4770
4. Blaydes JP, Luciani MG, Pospisilova S, Ball HM, Vojtesek B, Hupp TR (2001) Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription. J Biol Chem 276: 4699-4708, 4699-4708
5. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR (1991) The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061
6. Crook T, Marston NJ, Sara EA, Vousden KH (1994) Transcription activation by p53 correlates with suppression of growth but not transformation. Cell 79: 817-827
7. David-Pfeuty T, Chakrani F, Ory K, Nouvian-Dooghe Y (1996) Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells. Cell Growth Differ 7: 1211-1225
8. Hsieh J-K, Fredersdorf S, Kauzarides T, Martin K, Lu X (1997) E2F1 induced apoptosis requires DNA binding but not transcriptional activity and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev 11: 1840-1852
9. Hsieh JK, Yap D, O'Connor DJ, Fogal V, Fallis L, Chan F, Zhong S, Lu X (2002) Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Mol Cell Biol 22: 78-93
10. Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA, Sen S (2004) Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 36: 55-62
11. Li L, Ljungman M, Dixon JE (2000) The human Cdc14 phosphatases interact with and dephosphorylate the tumour suppressor protein p53. J Biol Chem. 275: 2410-2414
12. Li Y, Jenkins CW, Nichols MA, Xiong Y (1994) Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p53. Oncogene 9: 2261-2268
13. Merrick BA, Zhou W, Martin KJ, Jeyarajah S, Parker CE, Selkirk JK, Tomer KB, Borchers CH (2001) Site-specific phosphorylation of human p53 protein determined by mass spectrometry. Biochemistry 40: 4053-4066
14. O'Connor DJ, Lam EW-F, Griffin S, Zhong S, Leighton LC, Burbidge SA, Lu X (1995) Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1. EMBO 14: 6184-6192
15. Ohno A, Hirashima T, Kubo A, Masuda N, Takada M, Fujiwara H, Yasumitsu T, Kiku M, Fukuoka M, Nakagawa K (1997) p53 status and prognosis in stage I-IIIa non-small cell lung cancer. Int J Oncol 10: 521-528
16. Rogoff HA, Pickering MT, Debatis ME, Jones S, Kowalik TF (2002) E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol Cell Biol 22: 5308-5318
17. Rudolph B, Saffrich R, Zwicker J, Henglein B, Muller R, Ansorge W, Eilers M (1996) Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J 15: 3065-3076
18. Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG (2002) ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol 22: 1360-1368
19. Saito S, Goodarzi AA, Higashimoto Y, Noda Y, Lees-Miller SP, Appella E, Anderson CW (2002) ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J Biol Chem 277: 12491-12494
20. Sakaguchi K, Sakamoto H, Lewis MS, Anderson CW, Erickson JW, Appella E, Xie D (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36: 10117-10124
21. Shaulsky G, Ben-Se'ev A, Rotter V (1990) Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5: 1707-1711
22. Sherr CJ (1996) Cancer cell cycle. Science 274: 1672-1677
23. Shieh SY, Ikeda M, Taya Y, Prives C (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334
24. Soussi T, Caron DFC, Sturzbecher HW, Ullrich S, Jenkins J, May P (1989) Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70. J Virol 63: 3894-3901
25. Sturzbecher HW, Brain R, Addison C, Rudge K, Remm M, Grimaldi M, Keenan E, Jenkins JR (1992) A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene 7: 1513-1523
26. Szak ST, Mays D, Pietenpol JA (2001) Kinetics of p53 binding to promoter sites in vivo. Mol Cell Biol 21: 3375-3386
27. Wang Y, Prives C (1995) Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376: 88-91
28. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G (2001) The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414: 457-462
29. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ (1996) Tumour induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548
30. Yang A, Kaghad M, Wang Y, Gillet E, Fleming M, Dotsch V, Andrews N, Caput D, McKeon F (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316
31. Zhang Y, Xiong Y (2001) A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292: 1910-1915